Nanobiotix S.A.
NBTX
$28.23
-$2.08-6.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.97M | -64.69M | -73.73M | -55.32M | -36.20M |
| Total Depreciation and Amortization | 1.77M | 1.74M | 1.75M | 1.72M | 1.68M |
| Total Amortization of Deferred Charges | 4.40K | 3.30K | 2.20K | 2.20K | 2.20K |
| Total Other Non-Cash Items | 16.28M | 26.12M | 35.37M | 25.69M | 15.57M |
| Change in Net Operating Assets | 4.02M | 9.67M | 15.44M | 16.64M | 17.83M |
| Cash from Operations | -33.89M | -27.15M | -21.16M | -11.26M | -1.11M |
| Capital Expenditure | -550.50K | -728.60K | -915.10K | -727.50K | -534.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -119.20K | -118.30K | -118.00K | -75.00K | -30.40K |
| Cash from Investing | -669.70K | -846.90K | -1.03M | -802.40K | -564.30K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -4.60M | -4.38M | -4.16M | -4.04M | -3.93M |
| Issuance of Common Stock | -- | -- | -- | 30.08M | 60.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -707.00K | -843.50K | -980.00K | -5.48M | -9.97M |
| Cash from Financing | -5.78M | -5.60M | -5.55M | 22.09M | 50.07M |
| Foreign Exchange rate Adjustments | -508.00K | -192.70K | 101.60K | 56.60K | 10.60K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 600.00 | 1.10K | 1.10K | 1.00K |
| Net Change in Cash | -40.85M | -33.79M | -27.64M | 10.09M | 48.41M |